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Isoflavonoids possess enormous potential for human
health with potential impact on heart disease and
cancer, and somedisplay striking affinities for steroid
receptors. Synthesized primarily by legumes, isofla-
vonoids are present in low and variable abundance
within complex mixtures, complicating efforts to
assess their clinical potential. To satisfy the need
for controlled, efficient, and flexible biosynthesis
of isoflavonoids, a three-enzyme system has been
constructed in yeast that can convert natural and
synthetic flavanones into their corresponding isofla-
vones in practical quantities. Based on the determi-
nation of the substrate requirements of isoflavone
synthase, a series of natural and nonnatural isofla-
vones were prepared and their binding affinities for
the human estrogen receptors (ERa and ERb) were
determined. Structure activity relationships are sug-
gested based on changes to binding affinities related
to small variations on the isoflavone structure.INTRODUCTION
Among the classes of plant compounds that exhibit potentially
important biological activities are the isoflavonoids, three-ringed
compounds originating from the condensation of malonyl-CoA
and p-coumaric acid by a type III polyketide synthase (Chemler
et al., 2008). Isoflavones have been demonstrated to have an
impressive array of pharmacological activities and potential
benefits for human health in multiple areas including cardiovas-
cular disease (Siow et al., 2007; Squadrito et al., 2003), cancer
(Yamamoto et al., 2003), and other potential health-promoting
activities (Liu et al., 2006; Rasbach and Schnellmann, 2008;
Zhao and Brinton, 2007) although some occur at concentrations
unlikely to be attained from diet.
One particularly striking group of interactions is that of certain
isoflavones with steroid receptors (Ji et al., 2006; McCarty,
2006), most famously, the 100 nM interaction of genistein with
human estrogen receptor a (hERa) and the even more striking
10 nM affinity of genistein for human estrogen receptor b (hERb)
(Zhao and Brinton, 2005). Estrogen receptors are involved in392 Chemistry & Biology 17, 392–401, April 23, 2010 ª2010 Elseviernumerous developmental and biological interactions and the
precise response is determined by the interplay between
estrogen, the estrogen receptors, and an array of modifying
factors (Harris et al., 2005; Leung et al., 2006). Among the
goals of investigators looking for estrogen analogs has been
the discovery of molecules, referred to as selective estrogen
response modifiers or SERMs (Setchell, 2001), that elicit some
of estrogen’s effects but not others (Hollmer, 2006). Based on
their striking affinities for the estrogen and other steroid recep-
tors, the isoflavonoids are a potential class of drugs for modifying
estrogen action and metabolism.
The abundance of isoflavonoids from plants is generally low
and is determined by a host of environmental factors that vary
from year to year and locale to locale, to say nothing of the addi-
tional variability introduced in the supply chain from field to
processor to distributor to consumer (Mortensen et al., 2009).
In addition, the ‘‘active’’ isoflavonoids are present in undefined
mixtures and, in some natural extracts, components have mutu-
ally off-setting effects (Liew et al., 2003; Liu et al., 2007; Meezan
et al., 2005).
Chemical synthesis is certainly the preferred method for
making most isoflavonoids. However, for compounds with
multiple similar substitution sites like polyphenols or saccha-
rides, partial biosynthesis with natural or mutated enzymes
provides a means for the production of more defined com-
pounds in improved yield. The incorporation of natural and
hybrid biosynthetic pathways into microorganisms has created
the potential for not only the defined biosynthesis of a multitude
of natural products but also the opportunity to generate nonnat-
ural derivatives with potentially novel or refined pharmaceutical
activities (Minami et al., 2008; Willits et al., 2004). The ability to
do what amounts to combinatorial chemistry in microorganisms
by using a variety of natural or nonnatural precursors and dif-
ferent combinations of modifying enzymes has opened the
possibility of creating new compounds and at the same time
inventing the method for their synthesis (Challis and Hopwood,
2007; Chemler et al., 2007; Katsuyama et al., 2007a; Straathof
et al., 2002).
Presented here is an approach that combines organic syn-
thesis and metabolic engineering for the synthesis of natural
and nonnatural isoflavones in practical quantities in Saccharo-
myces cerevisiae. Based on the essential determination of the
substrate requirements of the key enzyme, isoflavone synthase
(IFS), this approach is the initial step in the construction of
a system for the potential synthesis of thousands of naturalLtd All rights reserved
Figure 1. Genistein Production Rates from
Naringenin in S. cerevisiae Shake Flask
Cultures
Rates are from the second day of fermentation.
Gm, G. max (soy bean); Tp, T. pratense (red
clover); Ge, G. enchinata (licorice); Mt, M. trunca-
tula (alfalfa); Ps, P. sativum (pea); Sc, S. cerevisiae
(yeast); Cr, C. roseus (Madagascar periwinkle).
Standard deviations are from triplicates.
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of the isoflavonoids begins with flavanones, which are converted
to isoflavones by the combined action of three enzymes: IFS
(Jung et al., 2000; Kim et al., 2003; Veitch, 2007), 2-hydroxyiso-
flavanone dehydratase (HID) (Akashi et al., 2005), and the cyto-
chrome P450 reductase (CPR) (Kim et al., 2005; Seeger et al.,
2003). The expression and interaction of these three plant
enzymes in S. cerevisiae enabled the biosynthesis of natural
and nonnatural isoflavones that displayed a spectrum of interac-
tions with ERa and ERb.
RESULTS AND DISCUSSION
Among Five IFS Genes Tested, Trifolium pratense IFS
Had the Highest Observed Activity When Expressed
in S. cerevisiae
A primary objective was the construction of a yeast strain that
would efficiently convert a diverse array of flavanone precursors
into natural and nonnatural isoflavones. The central enzyme in
this process is IFS and only limited data is available on the two
key selection criteria: relative conversion rates and substrate
flexibility. In order to find the best natural enzyme, sequences
from the approximately 25 known legume-derived IFS proteins
were compared. The IFS proteins were found to be highly cons-
erved; overall sequence identity among these proteins exceeded
80%. Consequently, the search for the best IFS was directed
toward those that had in some way been distinguished in the
literature: Glycine max (soy bean) because of the high levels of
isoflavones in soy beans and because of prior experience with
chimeric soy IFS (Leonard and Koffas, 2007; Tian and Dixon,
2006), Trifolium pratense (red clover) because of reportedChemistry & Biology 17, 392–401, April 23, 2010substrate flexibility and interaction with
coexpressed CPR (Kim et al., 2005), Gly-
cyrrhiza echinata (licorice) because of its
reported productivity in yeast (Kat-
suyama et al., 2007b), and Pisum sativum
(pea) and Medicago truncatula (alfalfa)
because of modest sequence differences
near the putative catalytic site.
The five IFS genes were cloned sepa-
rately into pYES2.1 yeast expression
vector under the control of the GAL1
promoter and transformed in yeast strain
INVSc1, where the necessary NADPH-
derived reducing equivalents would be
provided by the endogenous CPR. Each
strain was then grown in selective mini-
mal medium with galactose as an inducerand carbon source and supplemented with naringenin (Fig-
ure 1A). Conversion of naringenin to genistein was monitored
over 7 days with peak conversion rate observed on the second
day. Presented in Figure 1B, maximum observed production of
genistein by the cloned and expressed IFS genes was ranked
as follows: T. pratense > P. sativum > G. max R G. echinata >
M. truncatula. The IFS from T. pratense was selected as the
best candidate to continue work toward improving isoflavone
yields.
Conversion of Naringenin to Genistein by IFS
Is Dependent on the Source of the Supporting CPR
NADPH-derived reducing equivalents are transferred from CPR
to a recipient P450 enzyme like IFS by transient, direct contact
between the two membrane-bound enzymes. Interestingly, mul-
tiple eukaryotic microsomal P450 enzymes are supported by
a single endogenous CPR, which suggests a universal electron
transfer mechanism conserved among higher order species
allowing the possibility of a CPR to support heterogeneous P450
enzymes. However, the source of the CPR can influence the effi-
ciency of the coupled redox reaction as seen with P450s of plant
origin (Jennewein et al., 2005; Pompon et al., 1996; Ponnamper-
umaandCroteau, 1996) andeven the stereochemistry of the reac-
tion (Kraus andKutchan, 1995). Usingmicrosomesprepared from
yeast coexpressing T. pratense IFS and rice CPR, genistein
production from naringenin increased 4.3-fold (Kim et al., 2005).
Based on these examples, it was of interest to clone NADPH-
dependentCPRs fromdifferent sourcesandcompare theproduc-
tion rates of genisteinwhenoverexpressedwith thedifferent IFSs.
To examine the ability of particular CPRs to enhance IFS
activity in vivo, the CPR genes from Catharanthus roseusª2010 Elsevier Ltd All rights reserved 393
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pressed in S. cerevisiae cells with either IFS from G. max or
T. pratense (the sequence for the CPR from T. pratense was
not available). The CPRs from G. max and C. roseus have
66.2% protein identity with each other but only about 30%
protein identity with the CPR from yeast. CPR activity, the trans-
fer of electrons from NADPH to the P450 monooxygenase, was
determined indirectly by measuring the concentration of genis-
tein produced by the recombinant yeast fed with naringenin
and cultured over 7 days.
The maximum production rates were then compared to
yeast strains expressing only IFS supported by the endogenous
yeast CPR (Figure 1C). Coexpression of IFS and plant CPR
in yeast cells led to a significant increase in the production rate.
For example, the rate of genistein production increased by over
50% to 15 mg/liter/day, in yeast coexpressing T. pratense IFS
and G. max CPR. Coexpression of T. pratense IFS with the CPR
from C. roseus or S. cerevisiae had no significant effect on
production rates compared to control. When G. max IFS was
coexpressed with the CPR from G. max or C. roseus, maximum
product formation rates increased to 6.5 mg/liter/day, a 4-fold
rate increase over expression of G. max IFS alone. In contrast,
overexpression of yeast CPR with G. max IFS did not improve
the genistein production rate. These results suggest optimal pair-
ing of proteins is crucial for an efficient redox reaction.
HID from G. max Enhances Genistein Production Rate
The conversion of 2-hydroxyisoflavanones to isoflavones can
proceed spontaneously (Hashim et al., 1990) but in plants it is
facilitated by the enzyme HID. Only two HID enzymes have
been characterized and share 60.1% protein identity. The HID
from G. max displays a kinetic bias toward 2-hydroxyisoflava-
nones with a hydroxyl group at the C40 position while HID from
G. echinata has a higher activity toward substrates that bear
a C40 methoxy substituent (Akashi et al., 1999, 2005).
Demonstrations of the requirement for HID have been equiv-
ocal. In one attempt to reconstruct the isoflavone pathway in
hairy root cultures of the legume Lotus japonicus, the heterolo-
gous expression of G. echinata HID was determined to be a crit-
ical determinant of the accumulation of intracellular isoflavones
even though the concentration was modest (less than 0.5 mg/
liter) (Shimamura et al., 2007). In contrast, the expression of an
artificial chimera of IFS and CPR in E. coli yielded 4 mg/liter of
genistein without an HID (Leonard and Koffas, 2007). In con-
struction of an isoflavone-producing system, it is essential to
know if the coexpression of HID will increase productivity or
yield.
To determine whether HID could improve genistein production
activity in vitro, the soluble protein from yeast cells solely
expressing G. max HID was incubated with microsomes pre-
pared from yeast expressing only T. pratense IFS. The rate of
consumption of naringenin was monitored by HPLC and
compared to a control with soluble protein prepared from yeast
harboring an empty vector. The reaction containing HID
increased IFS rate of conversion of naringenin by 45% over
that of microsomes with IFS coincubated with the yeast soluble
protein devoid of HID.
The ability of HID to improve genistein production rate by IFS
was then examined in vivo. IFSs from T. pratense orG. maxwere394 Chemistry & Biology 17, 392–401, April 23, 2010 ª2010 Elseviercoexpressed with either G. max or G. echinata HID in yeast
cultures and the concentration of genistein was measured for
up to 7 days. For yeast cultures expressing T. pratense IFS,
the coexpression ofG.maxHID led to a 75% increase in themax-
imum genistein production rate; a 25% increase was observed
when G. echinata HID was expressed. For yeast cultures coex-
pressing G. max IFS and G. max HID, a 2-fold increase in the
maximum production rate was seen while coexpression of
G. max IFS with G. echinata HID had no effect on genistein
production rate (Figure 1D). These results demonstrate that the
G. max HID augments IFS activity and hence was selected for
construction of the isoflavone production pathway.
Reconstructing the Entire Isoflavone Biosynthesis
System Is the Key for Maximum Production
In order to reconstitute the optimal functional isoflavone syn-
thesis system within yeast cell cultures, the G. max and T. pra-
tense IFS genes were coexpressed with the available CPR
and HID genes. The hypothesis was that the complete system
would have a synergistic effect on the production of genistein
in yeast. HID and CPR genes under separate GAL1 promoters
were cloned onto yEPlac112; IFS was present on a separate
pYES2.1 vector. The yeast strains were constructed by trans-
forming both vectors into INVSc1 yeast cells sequentially and
the vectors were maintained on selective minimal SC medium.
Coexpression of the best single and double enzyme combina-
tions led to the construction of the yeast strain coexpressing
T. pratense IFS, G. max CPR, and G. max HID. This construct
improved genistein production rate by 15% compared to the
coexpression of G. max IFS withG. max HID, by 25% compared
to T. pratense IFS with G. max CPR, and by 200% compared to
expression of T. pratense IFS alone (Figure 1E). The combination
of T. pratense IFS, G. max HID, and C. roseus CPR provided no
improvement and was equivalent to the yeast strain coexpress-
ing only T. pratense IFS and C. roseus CPR.
The cognate combination ofG.max IFS, CPR, and HID yielded
significant improvements in genistein production rate over any
other combinations with the G. max IFS. The three-enzyme
combination was 50% more active compared to just IFS and
CPR, three times higher than IFS with only HID, and over ten
times faster than IFS alone. Despite different initial rates of the
strains, the final concentrations of genistein all maximized to
approximately the same level of about 35 mg/liter (Figure 2).
IFS Activity Is Substantially Inhibited by Genistein
and Biochanin A
One phenomenon observed during fermentations was the con-
sistent decrease in genistein production rate over time and
an apparent concentration ‘‘ceiling’’ noted above. The fall in
productivity cannot be accounted for by genistein’s low solubility
or by consumption of the precursor naringenin. To determine
whether isoflavones like genistein act as product inhibitors of
IFS, yeast microsomes containing T. pratense IFS were incu-
bated with a fixed concentration of naringenin and different
concentrations of either genistein, biochanin A, or genistin.
Similar studies were performed on microsomes prepared con-
taining the other IFSs but the consumption rates were too slow
to measure accurately. The consumption rate of naringenin
was monitored over 30 min and the rates were calculated asLtd All rights reserved
Figure 2. Genistein Production Curves from S. cerevisiae Coex-
pressing IFS, CPR, and HID
d: T. pratense IFS, G. max HID, G. max CPR.-: T. pratense IFS, G. max HID,
C. roseus CPR. >: G. max IFS, G. max HID, G. max CPR. 6: G. max IFS,
G. max HID, C. roseus CPR. Standard deviations are from triplicates.
Figure 3. Isoflavone Inhibition of the Conversion of 0.25 mM Narin-
genin by IFS
0.0025, 0.025, and 0.25 mM genistein are equivalent to 0.675, 6.75, and
67.5 mg/liter, respectively. Standard deviations are from duplicates.
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itor was present. When genistein was initially added, significant
inhibition was observed across three orders of magnitude
including a 34% decrease in IFS activity in the presence of
2.5 mM of genistein (Figure 3). An almost identical inhibition
profile was observed when the inhibitor was biochanin A (40-me-
thoxygenistein). In contrast, 0.25 mM genistin (genistein 7-O-
glucoside) exhibited no inhibition of the conversion of naringenin.
Based on these results it appears that binding to IFS is depen-
dent on the presence of an unmodified hydroxyl group at the
C7 position. The majority of isoflavonoids are accumulated in
the form of their glyco- and malonylconjugates in soybean
seeds. Acylation and glycosylation increases isoflavone solu-
bility and stability while enabling compartmentalization in
soy seeds (Heller and Forkmann, 1994). Isoflavone-modifying
enzymes such as glycosyltransferases and methyltransferases
(Dhaubhadel et al., 2008) may also alleviate product inhibition
of IFS by genistein.
All Five IFS EnzymesHave the SameSubstrate Flexibility
The second key selection criterion for IFS enzymes was
substrate flexibility. In principle, system substrate flexibility can
be maximized by combining IFS enzymes that accept different
subsets of flavanones as precursors. To determine whether
IFSs from different species had different substrate flexibility,
the five IFSs cloned into yeast were challenged against the
library of natural and nonnatural flavanones (Table 1 and
Figure 4).
Flavanones were purchased when possible but additional
flavanones were synthesized by reacting an appropriate aceta-
phenone and benzaldehyde to form a chalcone that was subse-
quently cyclized to yield the corresponding flavanone (see
Supplemental Information available online) (Huang et al., 1999;
Urgaonkar et al., 2005). Flavanones were designed to mimic
plant-derived flavanones and isoflavones. For example, all
natural flavonoids are hydroxylated at the C7 position of the
A ring while the C5 position may or may not be hydroxylated.
The resulting library of flavanones had many 7-monohydroxy-
lated and 5,7-dihydroxylated members. Natural flavanones andChemistry & Biology 17,isoflavones are further differentiated by single or multiple substi-
tutions on the B ring so the library was designed to consist of
flavanones with a variety of hydroxyl, fluoro, chloro, bromo,
methyl, methoxy, and ethoxy substituents at various positions
on the B ring. In total, 7 natural and 19 nonnatural flavanones
were available for assessment of IFS substrate flexibility.
Microsomes bearing the membrane-bound IFS along with the
endogenous S. cerevisiae CPR were prepared and incubated
with each flavanone for 24 hr and the reactions were analyzed
by reverse-phase HPLC. New products were identified in the
elution profiles by comparison with reactions performed with
yeast microsomes that lacked any IFS. Each IFS displayed the
same convertible substrate profile and no diversity in substrate
flexibility was observed. While this might be expected from the
high degree of sequence conservation, the practical conse-
quence is that the range of convertible substrates cannot be
expanded by exploiting natural variations among this ensemble
of IFSs. However, distinct criteria were observed that dictated
whether a flavanone was accepted as a substrate.Substrate Requirements for IFS Enzymes
While the panel of potential flavanone substrates is not compre-
hensive, a few suggestions about IFS substrate requirements
can be made from a survey of those flavanones that were
acceptable substrates. First, a hydroxyl group at the C7 position
is required to bind to the IFS as suggested by the conversion of
7-hydroxyflavanone but not flavanone itself. Second, hydroxyl-
ation at the C5 position is not necessary as the synthesis of
both genistein and daidzein proceeds without the need for an
intervening genistein dehydratase. Third, substitutions at the
C20 or C60 position (OH and Cl) were not tolerated, possibly
due to interference of the hydroxylation reaction at the C2 posi-
tion. Fourth, substitutions at the C30 and/or C50 position (OH, F,392–401, April 23, 2010 ª2010 Elsevier Ltd All rights reserved 395
Table 1. Biotransformations of Flavanones by the Isoflavone Pathway
R1 R2
Flavanone 5 7 20 30 40 50 Primary biotransformation product
Flavanone (1) H H H H H H NR
7-Hydroxyflavanone (2) H OH H H H H 3,7-Dihydroxydihydroflavonol (D1)
Pinocembrin (3) OH OH H H H H 3,5,7-Trihydroxydihydroflavonol (D2)
Naringenin (4) OH OH H H OH H Genistein (28)
Liquiritigenin (5) H OH H H OH H Diadzein (29)
Eriodictyol (6) OH OH H OH OH H Orobol (30)
Butina (7) H OH H OH OH H 30,40,7-Trihydroxyisoflavone (31)
20,40,5,7-Tetrahydroxyflavanonea (8) OH OH OH H OH H NR
Hesperitin (9) OH OH H OH OCH3 H NR
Homoeriodictyol (10) OH OH H OCH3 OH H 3
0-Methoxy-40,5,7-trihydroxyisoflavone (32)
40,7-Dihydroxy-30-methoxyflavanonea (11) H OH H OCH3 OH H 40,7-Dihydroxy-30-methoxyisoflavone (33)
30,50-Dimethoxy-40,5,7-trihydroxyflavanonea (12) OH OH H OCH3 OH OCH3 30,50-Dimethoxy-40,5,7-trihydroxyisoflavone (34)
40,7-Dihydroxy-30,50-dimethoxyflavanonea (13) H OH H OCH3 OH OCH3 40,7-Dihydroxy-30,50-dimethoxyisoflavone (35)
30-Ethoxy-40,5,7-trihydroxyflavanonea (14) OH OH H OCH2CH3 OH H 30-Ethoxy-40,5,7-trihydroxyflavanone (36)
40,7-Dihydroxy-30-ethoxyflavanonea (15) H OH H OCH2CH3 OH H 40,7-Dihydroxy-30-ethoxyflavanone (37)
30-Methyl-40,5,7-trihydroxyflavanonea (16) OH OH H CH3 OH H 30-Methyl-40,5,7-trihydroxyisoflavone (38)
40,7-Dihydroxy-30-methylflavanonea (17) H OH H CH3 OH H 40,7-Dihydroxy-30-methylisoflavone (39)
30,50-Dimethyl-40,5,7-trihydroxyflavanonea (18) OH OH H CH3 OH CH3 30,50-Dimethyl-40,5,7-trihydroxyisoflavone (40)
40,7-Dihydroxy-30,50-dimethylflavanonea (19) H OH H CH3 OH CH3 40,7-Dihydroxy-30,50-dimethylisoflavone (41)
5,7-Dihydroxy-40-fluoroflavanonea (20) OH OH H H F H NR
5,7-Dihydroxy-30-fluoroflavanonea (21) OH OH H F H H NR
5,7-Dihydroxy-20-fluoroflavanonea (22) OH OH F H H H NR
40-Chloro-5,7-dihydroxyflavanonea (23) OH OH H H Cl H NR
30-Chloro-40,5,7-trihydroxyflavanonea (24) OH OH H Cl OH H 30-Chloro-40,5,7-trihydroxyisoflavone (42)
30-Chloro-40,7-dihydroxyflavanonea (25) H OH H Cl OH H 30-Chloro-40,7-dihydroxyisoflavone (43)
30-Bromo-40,5,7-trihydroxyflavanonea (26) OH OH H Br OH H 30-Bromo-40,5,7-trihydroxyisoflavone (44)
30-Bromo-40,7-dihydroxyflavanonea (27) OH OH H Br OH H 30-Bromo-40,7-dihydroxyisoflavone (45)
NR, no reaction.
a Chemically synthesized for this study.
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was relatively small in size. Fifth, the presence of a C40 hydroxyl
group was an absolute requirement for 2-hydroxyisoflavanone
synthesis provided that all other criteria were met. Compounds
lacking any substitution on the B ring, as is the case with396 Chemistry & Biology 17, 392–401, April 23, 2010 ª2010 Elsevier7-hydroxyflavanone and pinocembrin (5,7-dihydroxyflavanone),
were converted by IFS but gave rise to corresponding dihydrox-
yflavonols (Table 1 and Figure 4B). Identical HPLC profiles
were obtained when the same two substrates were incubated
with flavanone 3b-hydroxylase from Malus domestica, whichFigure 4. Biotransformations of Flavanones
by the Isoflavone Pathway
(A) Conversion of 40-hydroxyflavanones into isofla-
vones.
(B) Conversion of 7-hydroxyflavanone and pino-
cembrin into dihydroflavonols.
Ltd All rights reserved
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(data not shown). The identification of dihydroflavonols corrects
a prior misinterpretation of substrate flexibility (Kim et al., 2003).
Therefore, the C40 hydroxyl group appears to be a strict require-
ment for ring migration. All of these observations are consistent
with a previous model of the mechanism of IFS (Hashim et al.,
1990).
The screening of a substrate library against IFS opened up the
ability to reexamine the role of key flavanone features required
for catalytic activity and how they might interact with residues
within the active site of the enzyme. No crystal structure of
IFS exists but previous docking experiments using homol-
ogy modeling of CYP93C2 (G. enchinata IFS) derived from
P450BM3 were performed to help identify key residues in the
catalytic site (Sawada et al., 2002). Using site-directed mutagen-
esis, residues Ser 310 and Lys 375 were identified to play roles in
the unique aryl migration from the C2 to the C3 position (Sawada
et al., 2002). Modification of Lys 375 led to complete abolition of
2-hydroxyisoflavanone synthesis and resulted in the exclusive
formation of a dihydroflavonol and/or flavone depending on
additional mutations. A follow up study identified Leu 371 to
play an important role in not only catalytic activity but protein
stability (Sawada and Ayabe, 2005). Both these studies pro-
posed that Lys 375 is an absolute requirement for aryl ring
migration and put forth a model that this residue interacts with
the C7 hydroxyl group on the flavanone substrate (Sawada and
Ayabe, 2005). The screening library used in this study identified
the necessity of a C40 hydroxyl group in order to obtain an isofla-
vone, andwith substrates lacking B ring substituents (7-hydroxy-
flavanone and pinocembrin) only the respective dihydroflavo-
nols were produced. With these two observations coupled with
the previous site mutagenesis results, we propose an alternative
role of Lys 375 as the residue directly involved in aryl ring migra-
tion. That is, Lys 375 binds to a flavanone’s C40 hydroxyl group
and possibly contributes to the shift reaction of the B ring from
the C2 to the C3 position. In addition, the hydroxyl group at the
C7 position appears to be necessary for binding to the catalytic
site since no product was observed when flavanone was the
substrate. A more likely residue for the C7 hydroxyl group to
bind towould then be the Ser 310 as the S310TCYP93C2mutant
lowered but did not abolish 2-hydroxyisoflavanone production
(Sawada et al., 2002). All of these observations, taken together,
may guide helpful modifications to a computer-based model of
IFS: substrate interactions (Sawada and Ayabe, 2005).
New Guidelines Identified for the Design of Isoflavone
as Potent Estrogen Receptor Agonists
Among the attributes of the soy isoflavones and their derivatives,
such as equol, is their remarkably high affinity for the human
estrogen receptors (Choi et al., 2008; Davis et al., 2008; Pinto
et al., 2008; Zhao and Brinton, 2005). Many of the most prom-
ising benefits of isoflavones in general and genistein in particular
appear to be mediated through interaction with ERb while
certain of the less encouraging effects take place through ERa
(McCarty, 2006). Further, the observations that estrogen-
replacement therapy promotes both cancer and chronic heart
fatigue have led to an intensive search for compounds that
promote the benefits of estrogen replacement therapy while
reducing some of its worrisome side effects (Hollmer, 2006).Chemistry & Biology 17,Along with six commercially available natural isoflavones and
one flavanone, 12 compounds of the series produced as
described above were evaluated for their direct interactions for
the human estrogen receptors ERa and ERb using commercially
available in vitro competitive binding assays and a time-resolved
fluorescence resonance energy transfer-capable microplate
reader (Figure 5). Only 13 out of 20 flavonoids showed binding
toward ERa and only 30-bromo-40,5,7-trihydroxyisoflavone was
equivalent to genistein for affinity for ERa (35 nM) (Table 2).
Only 16 out of 20 flavonoids showed binding toward ERb and
none had superior affinity than genistein for ERb (5 nM) (Table
2). All of the tested isoflavonoids had a higher selectivity (ERa
IC50/ERb IC50) for ERb, with the single exception of 3
0-chloro-
40,7-dihydroxyisoflavone with an a/b value of 0.4. The selectivity
for ERb was greatest for daidzein, genistein, and orobol with a/b
values greater than 5. Compounds such as 30-chloro-40,5,7-tri-
hydroxyisoflavone, 30-methyl-40,5,7-trihydroxyisoflavone, 40,7-
dihydroxy-30-methylisoflavone, 30,40,7-trihydroxyisoflavone, and
biochanin A also exhibited slight preference for ERb with a/b
values just over 2.
The presence of a hydroxyl group at the C5 position signifi-
cantly enhanced binding affinity for both ERa and ERb. Eight
isoflavone pairs differing by only the presence or lack of the
C5 hydroxyl group were compared. The genistein analogs
(with a C5 hydroxyl group) had at least a 4-fold lower IC50 value
for ERb than their daidzein counterparts, which lacked a C5
hydroxyl group. The same pattern was observed with ERa but
to an even greater degree. On average, the C5 hydroxyl group
reduced IC50 values by at least one order of magnitude.
Another trend observed was that substituents in the C30
position generally reduced affinity for both ERa and ERb as
an inverse to their relative bulk. For genistein analogs, the
substitution groups with decreasing affinity toward ERa went
as follows: Br > H > OH = CH3 > Cl > OCH3 > OCH2CH3. For
daidzein analogs, it went as follows: Cl > H > CH3 > OH >
Br > OCH3 > OCH2CH3. For genistein analogs, the substitution
groups with decreasing affinity toward ERb went as follows:
H > OH = Br > CH3 = Cl > OCH3 > OCH2CH3. For daidzein
analogs, it went as follows: H > CH3 > OH = Cl > OCH3 =
Br > OCH2CH3. The next generation of isoflavonoids designed
to interact with the estrogen receptors should have small sub-
stituents at the C30 position.
Modifications of hydroxyl groups give rise to the numerous
variations of isoflavones found in plant extracts. For instance,
the bulk of soy isoflavones are glycosylated (e.g., genistin) and
red clover isoflavones are primarily methylated (e.g., biochanin
A, prunetin, and formononetin). In either case, modifications of
the hydroxyl group at either the C7 or C40 position greatly
reduced their affinity to either estrogen receptor and increased
the IC50 values by at least a factor of ten compared to genistein.
Our understanding of the structure relationship between
isoflavones and estrogen receptors has benefited from the
extensive research on genistein and daidzein. Most notable is
that genistein is more estrogenic than daidzein, indicating the
importance of the C5 hydroxyl group to enhance binding (Fang
et al., 2001; Miksicek, 1994). After screening a number of natural
flavonoids, two QSAR models were proposed to describe the
ERa and ERb individually (Choi et al., 2008). The expanded
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Figure 5. Binding Affinities for ERa and ERb of Isoflavones
(A and B) d: estradiol,6: 28,,: 29,B: 30,>: 31.
(C and D)6: 32,,: 33,B: 42,>: 44. Standard deviations are from duplicates.
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phytoestrogens and estrogen receptors.
This study confirms the phytoestrogenic character of isofla-
vones and their remarkable interaction with estrogen receptors
at nanomolar levels. In particular, the rare natural compound
orobol and the unnatural 30-bromo-40,5,7-trihydroxyflavone
exhibited binding capabilities equivalent to that of genistein.
The results obtained from the screening library demonstrate
that estrogen receptor binding is strongly increased by hydroxyl
groups at positions C40, C5, and C7 and that C30 substituents
generally reduce the affinity. With these guidelines, a new series
of natural and nonnatural isoflavones can be prepared with the
aim of making compounds more specific than genistein for
ERa and ERb.
SIGNIFICANCE
Isoflavones have been demonstrated to have an impressive
array of pharmacological activities and potential benefits for
human health in multiple areas including cardiovascular
disease and cancer. Therefore, the establishment of an effi-
cient production platform is desired. This paper describes
the construction of an optimized three-enzyme system in
S. cerevisiae for the production of isoflavones. A number
of genes from various plant sources were screened for the
most active enzyme and enzyme combinations resulting in
a final construct with synergistic properties capable of
high isoflavone yields. Additionally, further insight into the398 Chemistry & Biology 17, 392–401, April 23, 2010 ª2010 ElsevierIFS mechanism was gained after screening the enzyme
against a library of synthetic flavanone precursors. The IFS
system was able to produce 4 natural isoflavones and 14
unnatural isoflavone analogs. Several isoflavones produced
by this system showed significant binding affinities to
human estrogen receptors, particularly the b isoform. Struc-
ture-activity relationships between the isoflavone structure
and the estrogen receptors were determined. The present
study furthers the development of mutasynthesis of natural
product analogs, particularly for systems involving cyto-
chrome P450 enzymes and their tailoring enzymes. Various
enzymes of plant and microbial origin can be readily incor-
porated together but identification of the most active
enzymes can lead to improved production rates and yields.
The biosynthesis of libraries of natural products and ana-
logs then allows the ability to screen for relevant biological
activities.EXPERIMENTAL PROCEDURES
Materials
Estradiol, glucose-6-phosphate, NADPH, and all materials for the chemical
synthesis of flavanones were purchased from Sigma-Aldrich (see Supple-
mental Experimental Procedures for flavanone reaction details). Genistein,
daidzein, biochanin A, prunetin, 30,40,7-trihydroxyisoflavone, genistin, flava-
none, 7-hydroxyflavanone, pinocembrin, liquiritigenin, naringenin, eriodictyol,
butin, homoeriodictyol, and hesperitin were purchased from Indofine. Mate-
rials for the LanthaScreen estrogen receptor assays were obtained directly
from Invitrogen.Ltd All rights reserved
Table 2. Estrogen Receptor IC50 Values of Natural and Unnatural Isoflavones
Ligand ERa IC50 (nM) ERb IC50 (nM) a/b
Estradiol 0.1 ± 0.0 0.2 ± 0.1 0.4
Genistein (28) 34.8 ± 12.0 5.4 ± 0.6 6.4
Daidzein (29) 485.4 ± 145.4 26.3 ± 6.7 18.5
Orobol (30) 70.8 ± 10.5 16.5 ± 5.6 4.3
30,40,7-Trihydroxyisoflavone (31) >1000 187 ± 96.4 NA
30-Methoxy-40,5,7-trihydroxyisoflavone (32) 880.3 ± 287.0 449.8 ± 74.0 2.0
40,7-Dihydroxy-30-methoxyisoflavone (33) >1000 706.4 ± 153.9 NA
30-Ethoxy-40,5,7-trihydroxyflavanone (36) >1000 >1000 NA
40,7-Dihydroxy-30-ethoxyflavanone (37) >1000 >1000 NA
30-Methyl-40,5,7-trihydroxyisoflavone (38) 69.3 ± 12.4 30.8 ± 9.5 2.2
40,7-Dihydroxy-30-methylisoflavone (39) 540.9 ± 159.5 70.8 ± 20.9 7.6
30,50-Dimethyl-40,5,7-trihydroxyisoflavone (40) >1000 155.4 ± 55.5 NA
40,7-Dihydroxy-30,50-dimethylisoflavone (41) >1000 >1000 NA
30-Chloro-40,5,7-trihydroxyisoflavone (42) 101.4 ± 32.3 39.5 ± 6.0 2.6
30-Chloro-40,7-dihydroxyisoflavone (43) 104.4 ± 41.7 208.7 ± 49.8 0.5
30-Bromo-40,5,7-trihydroxyisoflavone (44) 28.4 ± 10.5 17.1 ± 4.2 1.7
30-Bromo-40,7-dihydroxyisoflavone (45) >1000 841.5 ± 183.7 NA
Genistin (genistein-7-O-glucoside) >1000 >1000 NA
Prunetin (40,5-dihydroxy-7-methoxyisoflavone) 413.3 ± 91.5 299.4 ± 51.7 1.4
Biochantin A (5,7-dihydroxy-40-methoxyisoflavone) 465.4 ± 115.2 157.1 ± 24.1 3.0
Naringenin (4) 328.8 ± 127.2 186.4 ± 32.6 1.8
Standard deviation from duplicates. NA, not applicable.
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IFS fromGlycinemax (soy),Glycyrrhiza echinata (licorice),Medicago truncatula
(alfalfa), Pisum sativum (pea), and Trifolium pratense (red clover), HID from
Glycine max and Glycyrrhiza echinata, and CPR from Catharanthus roseus
(Madagascar periwinkle) and Glycine max were isolated from their respective
plants. First, the seeds were germinated in the dark at 30C in a growth
chamber to obtain etiolated seedlings. Seedlings were wounded either by
cutting small slits (1 mm sections) or exposed to UV for 5 min. Incubation
in the dark continued for 6 hr before harvesting. Harvested plant tissues
were flash frozen using liquid nitrogen and stored at 70C until further use.
RNAs from plant tissue were isolated using the RNeasy Plant Mini Kit
(QIAGEN). cDNAs were obtained from the RNAs first by reverse transcription
and then by PCR using the SuperScript One-Step RT-PCR with Platinum
Taq System (Invitrogen). Primers included in the reaction were designed
based on their respective sequence in GenBank. CPR from S. cerevisiae
was obtained directly using PCR of DNA isolated from yeast strain INVSc1
using the DNeasy Blood and Tissue Kit (QIAGEN) accordingly. Once each
gene was obtained, they were cloned into the pYES2.1-TOPO vector (Invitro-
gen), downstream of the GAL1 promoter. E. coli strain TOP10F0 (Invitrogen)
was used for plasmid maintenance and manipulation. All genes were
sequenced and errors found were corrected using the QuickChange Site-
Directed Mutagenesis Kit (Stratagene). Each HID and each CPR under a
GAL1 promoter was then cloned separately into YEplac112 (ATCC). The
YEplac112 plasmid harboring HID from G. max was then used to clone sepa-
rately CPR fromG.max andC. roseuswith their ownGAL1 promoter. pYES2.1
plasmids harboring an IFS transformed into S. cerevisiae strain INVSc1 (Invi-
trogen) or in combination with a YEplac112 plasmid harboring HID and/or
CPR. Positive transformants were selected by growth on uracil- and/or trypto-
phan-deficient SC yeast medium agar plates. A complete list of plasmids can
be found in Table S1.Production Curves of Genistein
Recombinant yeast cells were grown to saturation in 3 ml cultures for 2 days
at 30C on SC dropout media containing 2% glucose and lacking uracilChemistry & Biology 17,and/or tryptophan. Yeast cells were then quantified by spectrophotometry
at 600 nm. Yeast cultures at final OD600 of 0.8 were used to inoculate 5 ml
of SC dropout media containing 2% galactose and supplemented with
1.0 mM of the flavanone substrate naringenin [equivalent to 0.5 mM (2S)-nar-
ingenin]. Cultures were incubated at 30C to produce genistein. For isofla-
vone production analysis, 150 ml of culture was harvested and frozen for later
analysis. The thawed cultures were centrifuged to remove cell debris and the
supernatant was analyzed by HPLC. Naringenin and genistein concentrations
were quantified from 50 ml of sample directly injected into an HPLC system
(1100 series; Agilent) equipped with a ZORBAX SB-18 column (5 mm,
4.6 3 150 mm) held at 25C and a diode array detector. The isocratic mobile
phase at a flow rate of 1 ml/min consisted of 50% water, 35% methanol, and
15% acetonitrile. The elution time of naringenin was 7.08 min and of genistein
was 8.20 min. Concentrations were determined using authentic standards;
naringenin was quantified at 290 nm while genistein was quantified at
260 nm.Measurement of Inhibition of IFS by Isoflavones
Yeast microsomes from yeast harboring pYES2.1-TpIFS were prepared
according to the procedure previously described (Pompon et al., 1996), and
microsomal proteins were quantified colorimetrically (Protein Assay Dye
Reagent; Bio-Rad). Enzyme assays for determining the inhibition of the rate
at which IFS consumed naringenin by various isoflavones were performed at
25C in 2 ml vials at a final volume of 250 ml. Yeast microsomes (250 mg micro-
somal protein/reaction) were incubated with 0.0025, 0.025, and 0.25 mM
isoflavone (genistein, genistin, or biochanin A), 1 mM EDTA, and 0.25 mM nar-
ingenin in 50 mM Tris-HCl (pH 7.4). Nicotinamide cofactor recycle was per-
formed using 0.25 U/reaction of glucose-6-phophate dehydrogenase from
S. cerevisiae (Sigma-Aldrich) and 2.5 mM glucose-6-phosphate. Reactions
were initiated by adding 1 mM NADPH. Samples of 25 ml were taken every
10 min for 1 hr and injected directly for HPLC analysis. Percent inhibition of
the rate of consumption of naringenin was determined for three different isofla-
vone concentrations and compared to when no isoflavone was present
initially.392–401, April 23, 2010 ª2010 Elsevier Ltd All rights reserved 399
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of IFS with HID
Soluble yeast protein from yeast harboring pYES2.1-GmHID was prepared
according to the procedure previously described (Pompon et al., 1996) but
the supernatant obtained following cell lysis was saved and the insoluble
proteins and cell debris discarded. The total soluble protein was quantified
colorimetrically (Protein Assay Dye Reagent). In vitro assays using yeast
microsomes containing IFS from T. pratense were performed as previously
described but 125 mg of soluble yeast protein containing HID from G. max
was added. Percent increase of the rate of consumption of naringenin was
determined and compared to when no HID was added.
General Procedure for Bioconversion of Flavanone into Isoflavones
(Compounds 28–45)
Cultures of S. cerevisiae strain INVSc1 harboring the plasmids pYES2.1-
GmIFS and YEplac121-GmHID-CrCPR where grown in 3 ml of yeast SC
minimal knockout medium (without uracil and tryptophan) supplemented
with 2% glucose at 30C overnight. The next day, the preinoculum was added
to 100ml of yeast SCminimal knockoutmedium supplementedwith 2%galac-
tose so that the initial OD600 was 0.4. The appropriate flavanone dissolved
in DMSO was added to the culture to a final concentration of 0.1 mM. The cul-
tures were incubated in a horizontal shaker at 30C for 72 hr. Cells were then
removed by centrifugation and the aqueous medium was extracted three
times with ethyl acetate. The organic fractions were pooled and dried by rotary
evaporation and crude extracts were resuspended in 1:1 acetonitrile and
water. Purification was performed using an Agilent 1100 series HPLC with
a diode array detector using an Agilent semi-preparative C18 column (9.1 3
250 mm) held at 25C in line with a fraction collector. The isocratic mobile
phase used was 35% methanol and 15% acetonitrile in water.
Characterization of Unnatural Isoflavones
Purified unnatural isoflavones were characterized by their UV profile in 10:7:3
acetonitrile/methanol/water and by high resolution mass spectroscopy in
positive ionization as summarized in Table S2. Compounds 31, 32, 43, and
44 were chosen as representatives for 1H nuclear magnetic resonance spec-
troscopic studies and were prepared from 200 ml cultures in SC dropout
medium described above (see Supplemental Experimental Procedures).
Estrogen Receptor Assays
Estrogen receptor binding studies were conducted using Invitrogen’s
LanthaScreen ER alpha and beta competitive binding assay and performed
according to the manufacturer’s protocol. Time-resolved fluorescence reso-
nance energy transfer was measured using Bio-Tek’s Synergy 2 microplate
reader for excitation at 340 nm and detection of emission signals of terbium
at 495 nm and the tracer, Fluormone ES2 Green, at 520 nm. Purified unnatural
isoflavones and flavonoid standards were dissolved in DMSO and finally
diluted to 23 concentration in Invitrogen’s complete ES2 screening buffer so
that the final concentration of DMSO did not exceed 2% v/v. Each sample
was performed in at least duplicates. Final concentrations of substrates,
chosen to be evenly spaced on a logarithmic scale (incremented by 100.5),
were 5000, 1581, 500.0, 158.1, 50.00, 15.89, 5.000, 1.589, 0.5000, 0.1581,
0.0500, and 0.01581 nmol/liter. The IC50 values were determined as the
concentration of the competitor that produces 50% displacement of the tracer
used in the assay (3 nM). The IC50 values were calculated by a logistic three-
parameter curve fit with a Hill coefficient of 1.0 using Prism 5.0 (GraphPad)
and IC50 values with R
2 > 0.7 were reported else they were considered
non-binders.
SUPPLEMENTAL INFORMATION
Supplemental Information includes two tables and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.chembiol.2010.03.010.
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